PROfound: Efficacy of olaparib (ola) by prior taxane use in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations

De Bono J. S., Fizazi K., Saad F., Shore N. D., Roubaud G., Ozguroglu M., ...More

Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Costa Rica, 13 - 15 February 2020, vol.38 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 38
  • City: San-Francisco
  • Country: Costa Rica
  • Istanbul University Affiliated: Yes